Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New aryl formyl piperidine derivatives reversibly inhibiting MAGL for the treatment of depression

July 7, 2020

Potassium channel distancing fights stroke

July 6, 2020

Positive data presented from second pivotal phase III study of daridorexant

July 6, 2020

Takeda Pharmaceutical presents orexin OX2 receptor agonists

July 6, 2020

BlackThorn Therapeutics synthesizes vasopressin V1A antagonists

July 6, 2020

Neuren begins first-in-human study of oral NNZ-2591 in healthy volunteers

July 3, 2020

FDA approves Byfavo injection for the induction and maintenance of procedural sedation

July 3, 2020

Boehringer Ingelheim begins home-based phase II study of BI-1358894 for MDD

July 3, 2020

Dual CACNA2D1/mu-opioid receptor ligands discovered at Esteve

July 2, 2020

New gamma-secretase inhibitors identified at Roche

July 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...